NxThera Inc. raised $2 million from the sale of equity and warrants, according to documents filed with the Securities & Exchange Commission.
The St. Paul, Minn.-based startup is developing treatments for enlarged prostate using vapor injections and thermal energy to kill tissue.
Since December 2009, NxThera has raised $4 million from the sale of equity to investors including Arboretum Ventures, Aberdare Ventures and GDN Holdings, an investment firm run by former Medtronic vice chairman Dr. Glen Nelson.
NxThera CEO Robert Paulson formerly led Restore Medical Inc., a company based in Roseville, Minn., that focused on treating sleep apnea. Medtronic Inc. (NYSE:MDT) purchased Restore in 2008 for nearly $30 million.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.